Cargando…

Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study

Detalles Bibliográficos
Autores principales: Gouache, Elodie, Greze, Victoria, Strullu, Marion, Saultier, Paul, Fenneteau, Odile, Gandemer, Virginie, Ragu, Christine, Auvrignon, Anne, Boutroux, Hélène, Lapillonne, Hélène, Pasquet, Marlène, Leverger, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407794/
https://www.ncbi.nlm.nih.gov/pubmed/30887005
http://dx.doi.org/10.1097/HS9.0000000000000141
_version_ 1783401633880735744
author Gouache, Elodie
Greze, Victoria
Strullu, Marion
Saultier, Paul
Fenneteau, Odile
Gandemer, Virginie
Ragu, Christine
Auvrignon, Anne
Boutroux, Hélène
Lapillonne, Hélène
Pasquet, Marlène
Leverger, Guy
author_facet Gouache, Elodie
Greze, Victoria
Strullu, Marion
Saultier, Paul
Fenneteau, Odile
Gandemer, Virginie
Ragu, Christine
Auvrignon, Anne
Boutroux, Hélène
Lapillonne, Hélène
Pasquet, Marlène
Leverger, Guy
author_sort Gouache, Elodie
collection PubMed
description
format Online
Article
Text
id pubmed-6407794
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-64077942019-03-16 Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study Gouache, Elodie Greze, Victoria Strullu, Marion Saultier, Paul Fenneteau, Odile Gandemer, Virginie Ragu, Christine Auvrignon, Anne Boutroux, Hélène Lapillonne, Hélène Pasquet, Marlène Leverger, Guy Hemasphere Letter Wolters Kluwer Health 2018-08-13 /pmc/articles/PMC6407794/ /pubmed/30887005 http://dx.doi.org/10.1097/HS9.0000000000000141 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle Letter
Gouache, Elodie
Greze, Victoria
Strullu, Marion
Saultier, Paul
Fenneteau, Odile
Gandemer, Virginie
Ragu, Christine
Auvrignon, Anne
Boutroux, Hélène
Lapillonne, Hélène
Pasquet, Marlène
Leverger, Guy
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title_full Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title_fullStr Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title_full_unstemmed Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title_short Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
title_sort leukemia cutis in childhood acute myeloid leukemia: epidemiological, clinical, biological, and prognostic characteristics of patients included in the elam02 study
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407794/
https://www.ncbi.nlm.nih.gov/pubmed/30887005
http://dx.doi.org/10.1097/HS9.0000000000000141
work_keys_str_mv AT gouacheelodie leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT grezevictoria leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT strullumarion leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT saultierpaul leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT fenneteauodile leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT gandemervirginie leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT raguchristine leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT auvrignonanne leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT boutrouxhelene leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT lapillonnehelene leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT pasquetmarlene leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study
AT levergerguy leukemiacutisinchildhoodacutemyeloidleukemiaepidemiologicalclinicalbiologicalandprognosticcharacteristicsofpatientsincludedintheelam02study